Ricerca

Pubblicazioni IRIS

• Comparing Outcomes Between CPX-351 and Fludarabine-Based Induction in Secondary Acute Myeloid Leukemia in the Real-World Setting: The Prognostic Role of Measurable Residual Disease
  Anno: 2025
• Harnessing Immune Response in Acute Myeloid Leukemia
  Anno: 2023